293 related articles for article (PubMed ID: 26783250)
1. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
Yang Z; Zhao T; Liu H; Zhang L
Sci Rep; 2016 Jan; 6():19383. PubMed ID: 26783250
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma.
Liu S; Chen M; Li P; Wu Y; Chang C; Qiu Y; Cao L; Liu Z; Jia C
Cell Physiol Biochem; 2015; 36(2):499-508. PubMed ID: 25966742
[TBL] [Abstract][Full Text] [Related]
3. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
4. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
Li Q; Li B; Dong C; Wang Y; Li Q
Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells.
Xia T; Wang J; Wang Y; Wang Y; Cai J; Wang M; Chen Q; Song J; Yu Z; Huang W; Fang J
Oncotarget; 2016 May; 7(19):27336-49. PubMed ID: 27027340
[TBL] [Abstract][Full Text] [Related]
6. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
9. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/β‑catenin signaling pathway.
Xu L; Li J; Hou N; Han F; Sun X; Li Q
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):688-696. PubMed ID: 38584523
[TBL] [Abstract][Full Text] [Related]
11. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
Cheng Z; Yuan X; Qu Y; Li X; Wu G; Li C; Zu X; Yang N; Ke X; Zhou J; Xie N; Xu X; Liu S; Shen Y; Li H; Zhang W
Cancer Lett; 2017 Sep; 403():195-205. PubMed ID: 28645563
[TBL] [Abstract][Full Text] [Related]
12. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
[TBL] [Abstract][Full Text] [Related]
13. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST
Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873
[TBL] [Abstract][Full Text] [Related]
15. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
Zhang D; Ma X; Sun W; Cui P; Lu Z
Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876
[TBL] [Abstract][Full Text] [Related]
17. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
Gao Q; Zheng J
Cell Prolif; 2018 Jun; 51(3):e12438. PubMed ID: 29457293
[TBL] [Abstract][Full Text] [Related]
20. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
